Applied DNA Announces Closing of Upsized $12 Million Public Offering
STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LinearDNA–Applied DNA Sciences, Inc., (NASDAQ: APDN) (the “Company” or “Applied DNA”), a leader in polymerase chain reaction (“PCR”)-based technologies, today announced the closing of its previously announced public offering of 3,000,000 shares of its common stock (or common stock equivalents in lieu thereof), together with Series A warrants to purchase up … [Read more…]
